The CCK8 assay and colony formation assay revealed that co-treatment with Rapa significantly reduced the viability of ATM-deficient CRC cells compared with BMN673 treatment alone (Fig. 2u and Fig. S2m, n). This evidence concerns the gene TRERF1 and colorectal carcinoma.